title: Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study.
abstract: No data on whether brucellar meningitis or meningoencephalitis can be treated with oral antibiotics or whether an intravenous extended-spectrum cephalosporin, namely, ceftriaxone, which does not accumulate in phagocytes, should be added to the regimen exist in the literature. The aim of a study conducted in Istanbul, Turkey, was to compare the efficacy and tolerability of ceftriaxone-based antibiotic treatment regimens with those of an oral treatment protocol in patients with these conditions. This retrospective study enrolled 215 adult patients in 28 health care institutions from four different countries. The first protocol (P1) comprised ceftriaxone, rifampin, and doxycycline. The second protocol (P2) consisted of trimethoprim-sulfamethoxazole, rifampin, and doxycycline. In the third protocol (P3), the patients started with P1 and transferred to P2 when ceftriaxone was stopped. The treatment period was shorter with the regimens which included ceftriaxone (4.40 ± 2.47 months in P1, 6.52 ± 4.15 months in P2, and 5.18 ± 2.27 months in P3) (P = 0.002). In seven patients, therapy was modified due to antibiotic side effects. When these cases were excluded, therapeutic failure did not differ significantly between ceftriaxone-based regimens (n = 5/166, 3.0%) and the oral therapy (n = 4/42, 9.5%) (P = 0.084). The efficacy of the ceftriaxone-based regimens was found to be better (n = 6/166 [3.6%] versus n = 6/42 [14.3%]; P = 0.017) when a composite negative outcome (CNO; relapse plus therapeutic failure) was considered. Accordingly, CNO was greatest in P2 (14.3%, n = 6/42) compared to P1 (2.6%, n = 3/117) and P3 (6.1%, n = 3/49) (P = 0.020). Seemingly, ceftriaxone-based regimens are more successful and require shorter therapy than the oral treatment protocol.
authors.affiliation: Kasimpasa Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey. hakanerdem1969@yahoo.com
authors.forename: Hakan
authors.initials: H
authors.lastname: Erdem
authors.forename: Aysegül
authors.initials: A
authors.lastname: Ulu-Kilic
authors.forename: Selim
authors.initials: S
authors.lastname: Kilic
authors.forename: Mustafa
authors.initials: M
authors.lastname: Karahocagil
authors.forename: Ghaydaa
authors.initials: G
authors.lastname: Shehata
authors.forename: Necla
authors.initials: N
authors.lastname: Eren-Tulek
authors.forename: Funda
authors.initials: F
authors.lastname: Yetkin
authors.forename: Mustafa Kemal
authors.initials: MK
authors.lastname: Celen
authors.forename: Nurgul
authors.initials: N
authors.lastname: Ceran
authors.forename: Hanefi Cem
authors.initials: HC
authors.lastname: Gul
authors.forename: Gurkan
authors.initials: G
authors.lastname: Mert
authors.forename: Suda
authors.initials: S
authors.lastname: Tekin-Koruk
authors.forename: Murat
authors.initials: M
authors.lastname: Dizbay
authors.forename: Ayse Seza
authors.initials: AS
authors.lastname: Inal
authors.forename: Saygin
authors.initials: S
authors.lastname: Nayman-Alpat
authors.forename: Mile
authors.initials: M
authors.lastname: Bosilkovski
authors.forename: Dilara
authors.initials: D
authors.lastname: Inan
authors.forename: Nese
authors.initials: N
authors.lastname: Saltoglu
authors.forename: Laila
authors.initials: L
authors.lastname: Abdel-Baky
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Adeva-Bartolome
authors.forename: Bahadir
authors.initials: B
authors.lastname: Ceylan
authors.forename: Suzan
authors.initials: S
authors.lastname: Sacar
authors.forename: Vedat
authors.initials: V
authors.lastname: Turhan
authors.forename: Emel
authors.initials: E
authors.lastname: Yilmaz
authors.forename: Nazif
authors.initials: N
authors.lastname: Elaldi
authors.forename: Zeliha
authors.initials: Z
authors.lastname: Kocak-Tufan
authors.forename: Kenan
authors.initials: K
authors.lastname: Ugurlu
authors.forename: Basak
authors.initials: B
authors.lastname: Dokuzoguz
authors.forename: Hava
authors.initials: H
authors.lastname: Yilmaz
authors.forename: Sibel
authors.initials: S
authors.lastname: Gundes
authors.forename: Rahmet
authors.initials: R
authors.lastname: Guner
authors.forename: Nail
authors.initials: N
authors.lastname: Ozgunes
authors.forename: Asim
authors.initials: A
authors.lastname: Ulcay
authors.forename: Serhat
authors.initials: S
authors.lastname: Unal
authors.forename: Saim
authors.initials: S
authors.lastname: Dayan
authors.forename: Levent
authors.initials: L
authors.lastname: Gorenek
authors.forename: Ahmet
authors.initials: A
authors.lastname: Karakas
authors.forename: Yesim
authors.initials: Y
authors.lastname: Tasova
authors.forename: Gaye
authors.initials: G
authors.lastname: Usluer
authors.forename: Yasar
authors.initials: Y
authors.lastname: Bayindir
authors.forename: Behice
authors.initials: B
authors.lastname: Kurtaran
authors.forename: Oguz Resat
authors.initials: OR
authors.lastname: Sipahi
authors.forename: Hakan
authors.initials: H
authors.lastname: Leblebicioglu
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002002:Brucella / Q000187:drug effects* / Q000254:growth & development; D002006:Brucellosis / Q000188:drug therapy* / Q000382:microbiology; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D008590:Meningoencephalitis / Q000188:drug therapy / Q000382:microbiology; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D017211:Treatment Failure; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use; D014421:Turkey
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D004318:Doxycycline; D012293:Rifampin